CNS (Neoplasia Glioblastoma)

Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\CNS (Neoplasia Glioblastoma).php on line 2
CNS (Neoplasia Glioblastoma)

LE WE PMID CA

CNS (Neoplasia Glioblastoma)

1009

ZNS (Neubildung Glioblastom)

AZD2171

Bevacizumab ttVEGF

Caspase9

Chloroquine

Cilengitide ttRGD

Cimetidine

CNS (Neoplasia Astrocytoma)

CNS (Neoplasia Glioblastoma)

CNS (Neoplasia Glioma)

CNS (Neoplasia Gliosarcoma)

CNS (Neoplasia Oligodendroglioma)

Giant cell glioblastoma

Gliadel wafers

Interleukin24 MDA7

JNK

MTOR

Neoplasia (Tumor biology and immunology)

Neurostatin

PI3K

PTEN MMAC1 TEP1

Radiation therapy

RGD motif

Sec61

SEC61gamma

2010 1	New treatment options in the management of glioblastoma multiforme: a focus on bevacizumab. [20616955] Onco Targets Ther 3(-): 27-38 (2010)
2006 2	Cimetidine, an unexpected anti-tumor agent, and its potential for the treatment of glioblastoma (review). [16596218] Int J Oncol 28(5): 1021-30 (2006)
2010 3	Secondary gliosarcoma after diagnosis of glioblastoma: clinical experience with 30 consecutive patients. [19817543] J Neurosurg 112(5): 990-6 (2010)
2006 4	Congenital glioblastoma multiforme. Case report and review of the literature. [17184081] J Neurosurg 105(6 Suppl): 473-9 (2006)
2006 5	New trends in the medical management of glioblastoma multiforme: the role of temozolomide chemotherapy. [16709037] Neurosurg Focus 20(4): E6 (2006)
2006 6	Cellular signaling molecules as therapeutic targets in glioblastoma multiforme. [16709039] Neurosurg Focus 20(4): E8 (2006)
2006 7	Recurrent glioblastoma multiforme: a review of natural history and management options. [16709036] Neurosurg Focus 20(4): E5 (2006)
2006 8	Standard treatment and experimental targeted drug therapy for recurrent glioblastoma multiforme. [16709035] Neurosurg Focus 20(4): E4 (2006)
2006 9	Characteristics of tumor-associated endothelial cells derived from glioblastoma multiforme. [16709028] Neurosurg Focus 20(4): E22 (2006)
2006 10	Treatment options for glioblastoma. [16709025] Neurosurg Focus 20(4): E19 (2006)
2006 11	Gamma knife surgery for glioblastoma multiforme. [16709022] Neurosurg Focus 20(4): E17 (2006)
2008 12	Molecular predictors in glioblastoma: toward personalized therapy. [18625854] Arch Neurol 65(7): 877-83 (2008)
1999 13	Primary and secondary glioblastomas: from concept to clinical diagnosis. [11550301] Neuro Oncol 1(1): 44-51 (1999)
2008 14	PTEN signaling pathways in glioblastoma. [18836294] Cancer Biol Ther 7(9): 1321-5 (2008)
2009 15	Molecular mechanisms of necrosis in glioblastoma: the role of glutamate excitotoxicity. [19770591] Cancer Biol Ther 8(19): 1791-7 (2009)
2009 16	FDA drug approval summary: bevacizumab (Avastin) as treatment of recurrent glioblastoma multiforme. [19897538] Oncologist 14(11): 1131-8 (2009)
2009 17	Chloroquine in glioblastoma--new horizons for an old drug. [19326448] Cancer 115(11): 2380-3 (2009)
2011 18	Treatment advances for glioblastoma. [21955188] Expert Rev Neurother 11(10): 1343-5 (2011)
2008 19	Drug cocktails for effective treatment of glioblastoma multiforme. [18416653] Expert Rev Neurother 8(4): 515-7 (2008)
2008 20	Applications of emerging molecular technologies in glioblastoma multiforme. [18928343] Expert Rev Neurother 8(10): 1497-506 (2008)
2007 21	Malignant astrocytic glioma: genetics, biology, and paths to treatment. [17974913] Genes Dev 21(21): 2683-710 (2007)
2011 22	Mouse models to interrogate the implications of the differentiation status in the ontogeny of gliomas. [21896959] Oncotarget 2(8): 590-8 (2011)
2010 23	Targeting metabolic remodeling in glioblastoma multiforme. [21317451] Oncotarget 1(7): 552-62 (2010)
2009 24	New developments in targeted molecular therapies for glioblastoma. [19105702] Expert Rev Anticancer Ther 9(1): 7-10 (2009)
2008 25	MDA-7/IL-24 plus radiation enhance survival in animals with intracranial primary human GBM tumors. [18376144] Cancer Biol Ther 7(6): 917-33 (2008)
2009 26	Glioblastoma proto-oncogene SEC61gamma is required for tumor cell survival and response to endoplasmic reticulum stress. [19920201] Cancer Res 69(23): 9105-11 (2009)
2007 27	Long-term survival with glioblastoma multiforme. [17785346] Brain 130(Pt 10): 2596-606 (2007)
2010 28	Recent advances in therapy for glioblastoma. [20212224] Arch Neurol 67(3): 279-83 (2010)
2007 29	Gliadel wafers in the treatment of malignant glioma: a systematic review. [17938702] Curr Oncol 14(5): 189-94 (2007)
2010 30	Role of bevacizumab therapy in the management of glioblastoma. [21188100] Cancer Manag Res 2(-): 97-104 (2010)
2008 31	Cilengitide: an integrin-targeting arginine-glycine-aspartic acid peptide with promising activity for glioblastoma multiforme. [18616418] Expert Opin Investig Drugs 17(8): 1225-35 (2008)
2009 32	Cediranib: profile of a novel anti-angiogenic agent in patients with glioblastoma. [19671039] Expert Opin Investig Drugs 18(10): 1549-57 (2009)
2011 33	Antiangiogenic agents in the treatment of recurrent or newly diagnosed glioblastoma: analysis of single-agent and combined modality approaches. [21214925] Radiat Oncol 6(-): 2 (2011)
2011 34	Inhibitors of Glioma Growth that Reveal the Tumour to the Immune System. [22084619] Clin Med Insights Oncol 5(-): 265-314 (2011)
2011 35	Bevacizumab for the treatment of recurrent glioblastoma. [21603247] Clin Med Insights Oncol 5(-): 117-29 (2011)
2008 36	Giant cell glioblastoma: review of the literature and illustrated case. [18726045] Neurocirugia (Astur) 19(4): 343-9 (2008)
2011 37	Long-term survival with primary glioblastoma multiforme: a clinical study in bulgarian patients. [21537375] Case Rep Oncol 4(1): 1-11 (2011)
2011 38	Innovative Therapies against Human Glioblastoma Multiforme. [22091432] ISRN Oncol 2011(-): 787490 (2011)
2011 39	PI3Kinase signaling in glioblastoma. [21063898] J Neurooncol 103(3): 417-27 (2011)
2010 40	mTOR signaling in glioblastoma: lessons learned from bench to bedside. [20472883] Neuro Oncol 12(8): 882-9 (2010)
2010 41	Small molecule kinase inhibitors in glioblastoma: a systematic review of clinical studies. [20167819] Neuro Oncol 12(3): 304-16 (2010)
2010 42	Standard therapy for glioblastoma--a review of where we are. [20885105] Neurol Med Chir (Tokyo) 50(9): 713-9 (2010)
2011 43	Glioblastoma multiforme: a perspective on recent findings in human cancer and mouse models. [21429292] BMB Rep 44(3): 158-64 (2011)
2008 44	Glioblastoma multiforme: an emerging paradigm of anti-VEGF therapy. [18352856] Expert Opin Biol Ther 8(4): 541-53 (2008)
2009 45	STAT3 regulation of glioblastoma pathogenesis. [19601808] Curr Mol Med 9(5): 580-90 (2009)
2009 46	Current data and strategy in glioblastoma multiforme. [20108752] J Med Life 2(4): 386-93 (2009)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\CNS (Neoplasia Glioblastoma).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\CNS (Neoplasia Glioblastoma).php on line 92